Ligand validation:4GPH

BLA: BILIVERDINE IX ALPHA

BLA is a Ligand Of Interest in 4GPH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GPH_BLA_C_902	53%	7%	0.151	0.911	2.18	2.65	6	22	1	0	100%	0.3
4GPH_BLA_A_3002	36%	5%	0.191	0.885	2.53	2.74	8	20	2	0	100%	0.3
4GPH_BLA_B_601	9%	5%	0.241	0.735	2.11	3.12	8	29	3	0	100%	1
4GPC_BLA_C_901	73%	1%	0.111	0.938	3.99	3.9	23	24	0	0	100%	1
4GPF_BLA_A_901	40%	3%	0.156	0.865	3.32	2.66	12	23	5	0	100%	1
5B4J_BLA_A_301	98%	17%	0.055	0.981	2	1.61	10	5	0	0	100%	1
4EOC_BLA_A_1001	95%	8%	0.06	0.963	2.4	2.3	10	18	1	0	100%	0.9726
5VIQ_BLA_A_401	95%	4%	0.067	0.97	2.99	2.59	16	21	1	0	100%	1
3NB8_BLA_A_249	95%	9%	0.068	0.97	2.56	1.99	11	12	0	0	100%	1
7E2S_BLA_A_301	94%	9%	0.063	0.962	2.91	1.56	18	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.